XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ 988,621 $ (1,061,297)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock-based compensation 134,266 106,286
Depreciation 373,830 399,197
ESOP compensation expense 245,362 218,750
Gain on disposal of assets (2,000)
Deferred income tax benefit (50,336) (53,873)
Changes in assets and liabilities:    
(Increase) decrease in trade accounts receivable (289,088) 6,755,964
Decrease (increase) in income taxes receivable 158,439 (168,201)
Increase in inventories (152,211) (4,474,719)
Increase in prepaid expenses and other current assets (228,539) (55,565)
Decrease in accounts payable (619,925) (1,531)
Increase (decrease) in accrued salaries and wages 101,487 (117,859)
Increase in vacation accrual 79,846 83,430
Decrease in ESOP Payable (75,000)
Increase (decrease) in other accrued expenses 145,789 (160,678)
(Decrease) increase in payroll and other taxes withheld (350,924) 278,375
Increase in contract liabilities 276,461 562,728
Decrease in income taxes payable (47,707)
Net cash provided by operating activities 811,078 2,188,300
Cash Flows from Investing Activities:    
Additions to property, plant and equipment (216,500) (34,337)
Proceeds from sale of fixed assets 2,000
Purchase of investment securities (3,692,458) (4,294,897)
Proceeds from sale/maturity of investment securities 3,576,000 6,429,064
Net cash (used in) provided by investing activities (330,958) 2,099,830
Cash Flows from Financing Activities:    
Dividends on common stock (1,201,316)
Net cash used in financing activities (1,201,316)
Increase in cash and cash equivalents 480,120 3,086,814
Cash and cash equivalents, beginning of period 6,802,712 5,402,122
Cash and cash equivalents, end of period 7,282,832 8,488,936
Supplemental Schedule of Cash Flow Information:    
Income taxes paid $ 120,000 $ 175,250